GGMC Educational Webinar Series: A Case for Extracellular Vesicles

The burgeoning field of extracellular vesicle (EV) signalling holds the potential to revolutionise our understanding of cancer biology and offers new avenues for non-invasive diagnostics and therapeutic interventions. EVs have been implicated in various aspects of cancer progression, including tumour initiation, metastasis, and response to therapy. From the early stages of tumour development, tumour-derived EVs are detectable in the circulation.

Professor Salomon is the head of the Translational Extracellular Vesicles in Obstetrics and Gynae-Oncology Group, NHMRC Investigator Fellow and is considered a worldwide authority on Extracellular Vesicles biomarkers for complications of pregnancies and ovarian cancer (165 publications, H index 51, i10-index = 121). In the last 10 years, Professor Salomon’s primary research and commercialisation activities have focused on the identification and validation of biomarkers, and development of In Vitro Multivariate Index Assays for clinically relevant complications (including ovarian cancers, and obstetrical syndromes) and their translation into clinical applications. He is a pioneer on investigation the release of extracellular vesicles (EVs) by the placenta and tumour cells and their utility as a biomarker for a wide range of pregnancy complications and ovarian cancer (OC).

Leave a Reply

Your email address will not be published. Required fields are marked *